SCHEDULE 13G

Statement of Beneficial Ownership

LENZ Therapeutics, Inc. Filed 2026-04-08 Acc 0001642575-26-000004

Documents 1

SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

2026-04-27 SCHEDULE 13G Statement of Beneficial Ownership
2026-04-08 SCHEDULE 13G Statement of Beneficial Ownership
2025-11-07 SCHEDULE 13G Statement of Beneficial Ownership

Link to a passage

External

SEC EDGAR (opens in new tab)